Anne Stava-Murray supports HB3454 regarding FDA-approved epinephrine devices in 116-0 House vote
Rep. Anne Stava-Murray (D-81st) cast a Yes vote on HB3454, a bill addressing epinephrine delivery devices, during the 104th General Assembly on May 31, 2026, according to the Illinois House. The legislation was unanimously approved in the House by a 116-0 vote.
Per the official bill text, the measure is titled: "EPINEPHRINE DELIVERY DEVICE."
The summary below provides clarification and analysis derived from the official bill language to illuminate key provisions.
The legislation updates several Illinois Acts to replace terms like "epinephrine auto-injector" or "epinephrine injector" with "FDA approved epinephrine delivery device or product." It changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act. The measure establishes updated guidelines for law enforcement agencies and schools relating to the training and use of these devices in anaphylactic emergencies, covers immunity from liability for personnel administering devices in good faith, and calls for clear policies about device acquisition, storage, and use. It also institutes mandatory reporting to the State Board of Education when a device is administered, explains cost structures for procurement and training, ensures insurers provide coverage for minors, and amends laws related to public health and emergency response.
The bill's noted legislative action was 'Senate Floor Amendment No. 2 House Concurs'.
Stava-Murray earned a BA from Dartmouth College in 2008.
Stava-Murray, a Democrat, was first elected to serve Illinois' 81st House District in 2019, succeeding David S. Olsen as state representative.
In Illinois, legislation goes through a structured, multi-step process, beginning with introduction in either legislative chamber, evaluation by committees, floor discussion, and votes in both the House and Senate before being submitted to the governor for signature or veto. The Illinois General Assembly meets on a biennial basis. While lawmakers introduce thousands of bills each session, only a small percentage are ultimately approved and enacted.